A novel ELISA system for selective measurement of human adiponectin multimers by using proteases

Adiponectin, an antiatherogenic adipocyte-derived protein exists in human blood as multiple isoforms—trimeric low molecular weight (LMW), albumin-binding LMW (Alb-LMW), hexameric middle molecular weight (MMW), and high molecular weight (HMW) forms. We developed a novel ELISA system to detect total h...

Full description

Saved in:
Bibliographic Details
Published inClinica chimica acta Vol. 372; no. 1; pp. 47 - 53
Main Authors Ebinuma, Hiroyuki, Miyazaki, Osamu, Yago, Hirokazu, Hara, Kazuo, Yamauchi, Toshimasa, Kadowaki, Takashi
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.10.2006
Subjects
Online AccessGet full text
ISSN0009-8981
1873-3492
DOI10.1016/j.cca.2006.03.014

Cover

Abstract Adiponectin, an antiatherogenic adipocyte-derived protein exists in human blood as multiple isoforms—trimeric low molecular weight (LMW), albumin-binding LMW (Alb-LMW), hexameric middle molecular weight (MMW), and high molecular weight (HMW) forms. We developed a novel ELISA system to detect total human adiponectin and the selective level of each adiponectin multimer for investigating the distribution of these levels in human blood. Two monoclonal antibodies that were raised against human adiponectin were used to construct a sandwich ELISA to measure adiponectin levels. Adiponectin multimers were selectively measured after sample pretreatment with two proteases that specifically digested the trimeric forms or both the hexameric and trimeric forms. The ELISA had a dynamic range of 0.075–4.8 ng/ml. Intraassay variations (CV) were 5.3% (total adiponectin), 4.1% (MMW + HMW), and 3.3% (HMW). Comparison of the results of ELISA and quantitative western blot analysis of multimeric adiponectin in serum samples revealed good correlation (LMW + Alb-LMW, r = 0.873; MMW, r = 0.907; HMW, r = 0.950). Each of the three forms of adiponectin multimer levels closely correlated with total adiponectin levels in healthy subjects. This ELISA system can be used to further investigate the physiological roles of human adiponectin multimers.
AbstractList Adiponectin, an antiatherogenic adipocyte-derived protein exists in human blood as multiple isoforms—trimeric low molecular weight (LMW), albumin-binding LMW (Alb-LMW), hexameric middle molecular weight (MMW), and high molecular weight (HMW) forms. We developed a novel ELISA system to detect total human adiponectin and the selective level of each adiponectin multimer for investigating the distribution of these levels in human blood. Two monoclonal antibodies that were raised against human adiponectin were used to construct a sandwich ELISA to measure adiponectin levels. Adiponectin multimers were selectively measured after sample pretreatment with two proteases that specifically digested the trimeric forms or both the hexameric and trimeric forms. The ELISA had a dynamic range of 0.075–4.8 ng/ml. Intraassay variations (CV) were 5.3% (total adiponectin), 4.1% (MMW + HMW), and 3.3% (HMW). Comparison of the results of ELISA and quantitative western blot analysis of multimeric adiponectin in serum samples revealed good correlation (LMW + Alb-LMW, r = 0.873; MMW, r = 0.907; HMW, r = 0.950). Each of the three forms of adiponectin multimer levels closely correlated with total adiponectin levels in healthy subjects. This ELISA system can be used to further investigate the physiological roles of human adiponectin multimers.
Adiponectin, an antiatherogenic adipocyte-derived protein exists in human blood as multiple isoforms--trimeric low molecular weight (LMW), albumin-binding LMW (Alb-LMW), hexameric middle molecular weight (MMW), and high molecular weight (HMW) forms. We developed a novel ELISA system to detect total human adiponectin and the selective level of each adiponectin multimer for investigating the distribution of these levels in human blood.BACKGROUNDAdiponectin, an antiatherogenic adipocyte-derived protein exists in human blood as multiple isoforms--trimeric low molecular weight (LMW), albumin-binding LMW (Alb-LMW), hexameric middle molecular weight (MMW), and high molecular weight (HMW) forms. We developed a novel ELISA system to detect total human adiponectin and the selective level of each adiponectin multimer for investigating the distribution of these levels in human blood.Two monoclonal antibodies that were raised against human adiponectin were used to construct a sandwich ELISA to measure adiponectin levels. Adiponectin multimers were selectively measured after sample pretreatment with two proteases that specifically digested the trimeric forms or both the hexameric and trimeric forms.METHODSTwo monoclonal antibodies that were raised against human adiponectin were used to construct a sandwich ELISA to measure adiponectin levels. Adiponectin multimers were selectively measured after sample pretreatment with two proteases that specifically digested the trimeric forms or both the hexameric and trimeric forms.The ELISA had a dynamic range of 0.075-4.8 ng/ml. Intraassay variations (CV) were 5.3% (total adiponectin), 4.1% (MMW+HMW), and 3.3% (HMW). Comparison of the results of ELISA and quantitative western blot analysis of multimeric adiponectin in serum samples revealed good correlation (LMW+Alb-LMW, r=0.873; MMW, r=0.907; HMW, r=0.950). Each of the three forms of adiponectin multimer levels closely correlated with total adiponectin levels in healthy subjects.RESULTSThe ELISA had a dynamic range of 0.075-4.8 ng/ml. Intraassay variations (CV) were 5.3% (total adiponectin), 4.1% (MMW+HMW), and 3.3% (HMW). Comparison of the results of ELISA and quantitative western blot analysis of multimeric adiponectin in serum samples revealed good correlation (LMW+Alb-LMW, r=0.873; MMW, r=0.907; HMW, r=0.950). Each of the three forms of adiponectin multimer levels closely correlated with total adiponectin levels in healthy subjects.This ELISA system can be used to further investigate the physiological roles of human adiponectin multimers.CONCLUSIONSThis ELISA system can be used to further investigate the physiological roles of human adiponectin multimers.
Adiponectin, an antiatherogenic adipocyte-derived protein exists in human blood as multiple isoforms--trimeric low molecular weight (LMW), albumin-binding LMW (Alb-LMW), hexameric middle molecular weight (MMW), and high molecular weight (HMW) forms. We developed a novel ELISA system to detect total human adiponectin and the selective level of each adiponectin multimer for investigating the distribution of these levels in human blood. Two monoclonal antibodies that were raised against human adiponectin were used to construct a sandwich ELISA to measure adiponectin levels. Adiponectin multimers were selectively measured after sample pretreatment with two proteases that specifically digested the trimeric forms or both the hexameric and trimeric forms. The ELISA had a dynamic range of 0.075-4.8 ng/ml. Intraassay variations (CV) were 5.3% (total adiponectin), 4.1% (MMW+HMW), and 3.3% (HMW). Comparison of the results of ELISA and quantitative western blot analysis of multimeric adiponectin in serum samples revealed good correlation (LMW+Alb-LMW, r=0.873; MMW, r=0.907; HMW, r=0.950). Each of the three forms of adiponectin multimer levels closely correlated with total adiponectin levels in healthy subjects. This ELISA system can be used to further investigate the physiological roles of human adiponectin multimers.
Author Yago, Hirokazu
Ebinuma, Hiroyuki
Kadowaki, Takashi
Yamauchi, Toshimasa
Miyazaki, Osamu
Hara, Kazuo
Author_xml – sequence: 1
  givenname: Hiroyuki
  surname: Ebinuma
  fullname: Ebinuma, Hiroyuki
  email: ebinuma@daiichichem.co.jp
  organization: Diagnostics Research Laboratories, Daiichi Pure Chemicals Co. Ltd., 3-3-1, Koyodai, Ryugasaki, Ibaraki 301-0852, Japan
– sequence: 2
  givenname: Osamu
  surname: Miyazaki
  fullname: Miyazaki, Osamu
  organization: Diagnostics Research Laboratories, Daiichi Pure Chemicals Co. Ltd., 3-3-1, Koyodai, Ryugasaki, Ibaraki 301-0852, Japan
– sequence: 3
  givenname: Hirokazu
  surname: Yago
  fullname: Yago, Hirokazu
  organization: Diagnostics Research Laboratories, Daiichi Pure Chemicals Co. Ltd., 3-3-1, Koyodai, Ryugasaki, Ibaraki 301-0852, Japan
– sequence: 4
  givenname: Kazuo
  surname: Hara
  fullname: Hara, Kazuo
  organization: Department of Clinical Bioinformatics, Graduate School of Medicine, University of Tokyo 113-8655, Japan
– sequence: 5
  givenname: Toshimasa
  surname: Yamauchi
  fullname: Yamauchi, Toshimasa
  organization: Department of Metabolic Diseases, Graduate School of Medicine, University of Tokyo 113-8655, Japan
– sequence: 6
  givenname: Takashi
  surname: Kadowaki
  fullname: Kadowaki, Takashi
  organization: Department of Metabolic Diseases, Graduate School of Medicine, University of Tokyo 113-8655, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16697359$$D View this record in MEDLINE/PubMed
BookMark eNp9kEFrHCEUgKUkNJu0P6CX4qm3meg6OkpPS0jbwEIPTc7G0Tety-hs1VnYfx_DphRyyEkefN978l2iszhHQOgTJS0lVFzvWmtNuyZEtIS1hHbv0IrKnjWsU-sztCKEqEYqSS_QZc67OnZE0PfoggqhesbVCj1ucJwPMOHb7d2vDc7HXCDgcU44wwS2-APgACYvCQLEgucR_1mCidg4v6-_qUTEYZmKD5AyHo54yT7-xvs0l6pB_oDORzNl-PjyXqGHb7f3Nz-a7c_vdzebbWM72peGOScEoZwaZgVIzjgXa-4GxchAByuZYo53lq87q8YOVC8tlVxJ60bDnAJ2hb6c9tbLfxfIRQefLUyTiTAvWQvZSyEZq-DnF3AZAji9Tz6YdNT_mlSAngCb5pwTjP8Rop-7652u3fVzd02Yrt2r079yrC-m-DmWZPz0pvn1ZEKNc_CQdLYeogXnU62r3ezfsJ8AvgOcuQ
CitedBy_id crossref_primary_10_1016_j_jdiacomp_2012_02_008
crossref_primary_10_1038_hr_2010_282
crossref_primary_10_1038_nutd_2012_18
crossref_primary_10_1089_chi_2016_0135
crossref_primary_10_1530_EJE_10_0021
crossref_primary_10_1016_j_diabres_2017_03_020
crossref_primary_10_1038_ijo_2008_233
crossref_primary_10_1007_s00125_006_0452_8
crossref_primary_10_1016_j_heliyon_2021_e07851
crossref_primary_10_1097_MCO_0b013e3282bf6ea8
crossref_primary_10_1038_ijo_2016_103
crossref_primary_10_1016_j_metabol_2009_03_005
crossref_primary_10_1507_endocrj_EJ12_0277
crossref_primary_10_1016_j_cca_2008_11_013
crossref_primary_10_1111_jdi_12133
crossref_primary_10_3109_0886022X_2010_494804
crossref_primary_10_1161_HYPERTENSIONAHA_109_132522
crossref_primary_10_1210_jc_2010_0716
crossref_primary_10_1016_j_jdermsci_2009_02_009
crossref_primary_10_3945_ajcn_2009_28151
crossref_primary_10_1016_j_earlhumdev_2016_01_022
crossref_primary_10_1093_ajcn_87_2_347
crossref_primary_10_3109_1354750X_2010_533286
crossref_primary_10_1111_j_1365_2265_2008_03385_x
crossref_primary_10_1177_1099800410371824
crossref_primary_10_1186_2193_1801_1_66
crossref_primary_10_1111_j_1442_200X_2009_02853_x
crossref_primary_10_1373_clinchem_2007_090670
crossref_primary_10_1373_clinchem_2007_085654
crossref_primary_10_1016_j_nut_2013_02_005
crossref_primary_10_1080_14767050802266881
crossref_primary_10_1016_j_clinthera_2009_10_010
crossref_primary_10_1002_pros_20823
crossref_primary_10_1111_j_1365_2362_2008_02028_x
crossref_primary_10_1515_CCLM_2007_313
crossref_primary_10_2460_ajvr_73_8_1230
crossref_primary_10_1186_1471_2431_12_139
crossref_primary_10_1345_aph_1M640
crossref_primary_10_1016_j_exger_2022_111821
crossref_primary_10_1152_ajpregu_00575_2012
crossref_primary_10_1210_jc_2007_0890
crossref_primary_10_3109_13547501003735532
crossref_primary_10_1507_endocrj_EJ14_0626
crossref_primary_10_1111_j_1939_165X_2009_00133_x
crossref_primary_10_37349_emed_2023_00120
crossref_primary_10_1186_1477_7827_11_99
crossref_primary_10_2337_dc06_1362
crossref_primary_10_2169_internalmedicine_51_8636
crossref_primary_10_1016_j_earlhumdev_2014_02_009
crossref_primary_10_1111_j_1442_200X_2011_03420_x
crossref_primary_10_2337_db07_0185
crossref_primary_10_1016_j_metop_2023_100264
crossref_primary_10_1002_smsc_202200009
crossref_primary_10_5494_wjh_v2_i1_13
crossref_primary_10_1152_ajpendo_00089_2007
crossref_primary_10_1177_0003319713520463
crossref_primary_10_1016_j_bbrc_2007_07_106
crossref_primary_10_1016_j_cca_2006_07_026
crossref_primary_10_1111_j_1463_1326_2008_00899_x
crossref_primary_10_1016_j_pnpbp_2007_07_022
crossref_primary_10_18585_inabj_v2i1_113
crossref_primary_10_1111_j_1755_5922_2008_00069_x
crossref_primary_10_1152_japplphysiol_01046_2012
crossref_primary_10_1016_j_cca_2009_04_018
crossref_primary_10_1111_j_1365_2265_2007_02991_x
crossref_primary_10_2169_internalmedicine_54_3596
crossref_primary_10_5372_1905_7415_0805_332
crossref_primary_10_1016_j_domaniend_2019_07_008
crossref_primary_10_1203_PDR_0b013e3181995103
crossref_primary_10_1530_EJE_09_0756
crossref_primary_10_1016_j_nut_2012_07_011
crossref_primary_10_1016_j_metabol_2010_02_019
crossref_primary_10_1016_j_jpeds_2007_07_047
crossref_primary_10_1016_j_cca_2010_09_007
crossref_primary_10_1002_oby_20553
crossref_primary_10_1016_j_atherosclerosis_2007_09_036
crossref_primary_10_1016_j_cca_2017_07_014
crossref_primary_10_18585_inabj_v1i1_82
crossref_primary_10_1016_j_metabol_2009_12_011
crossref_primary_10_1042_BJ20071492
crossref_primary_10_1007_s10157_021_02085_w
crossref_primary_10_1210_jc_2012_3342
crossref_primary_10_1016_j_diabet_2007_08_002
crossref_primary_10_1530_EJE_07_0213
crossref_primary_10_3889_oamjms_2015_098
crossref_primary_10_1210_er_2006_0033
crossref_primary_10_1371_journal_pone_0192609
crossref_primary_10_1007_s12014_009_9036_1
crossref_primary_10_1249_MSS_0b013e31816a9ee5
crossref_primary_10_1016_j_atherosclerosis_2013_04_014
crossref_primary_10_1038_ejcn_2014_152
crossref_primary_10_3389_fimmu_2020_569883
crossref_primary_10_1002_phar_1713
crossref_primary_10_1515_JPM_2009_116
crossref_primary_10_3109_00016341003657918
crossref_primary_10_1016_j_cca_2016_12_009
crossref_primary_10_1111_j_2040_1124_2010_00091_x
crossref_primary_10_1515_CCLM_2010_104
crossref_primary_10_1159_000354037
crossref_primary_10_1016_j_metabol_2007_11_012
crossref_primary_10_1016_j_bbrc_2008_08_111
crossref_primary_10_1038_oby_2009_441
crossref_primary_10_1016_j_biopha_2018_03_003
crossref_primary_10_1042_CS20070387
crossref_primary_10_14341_probl12827
crossref_primary_10_1016_S0828_282X_08_71033_X
crossref_primary_10_1210_jc_2010_1835
crossref_primary_10_2217_17520363_2_3_239
crossref_primary_10_1111_j_1365_2265_2009_03674_x
crossref_primary_10_1016_j_jcyt_2014_05_005
crossref_primary_10_1007_s13340_015_0204_4
crossref_primary_10_1016_j_jacc_2010_11_011
crossref_primary_10_1530_EJE_07_0512
crossref_primary_10_1149_2_0111909jes
crossref_primary_10_1016_j_metabol_2017_01_002
crossref_primary_10_1016_S0929_6646_09_60079_6
crossref_primary_10_1016_j_clinbiochem_2009_06_003
crossref_primary_10_1155_2022_7480579
crossref_primary_10_1210_jc_2006_1051
crossref_primary_10_1210_jc_2014_1896
crossref_primary_10_1371_journal_pone_0206802
crossref_primary_10_1530_EJE_08_0727
Cites_doi 10.1161/01.CIR.103.8.1057
10.1093/oxfordjournals.jbchem.a021483
10.2337/diabetes.53.6.1621
10.1016/S0140-6736(03)12255-6
10.1006/bbrc.1996.0587
10.1074/jbc.M311113200
10.1111/j.1749-6632.1964.tb14213.x
10.2337/diacare.26.7.2015
10.1074/jbc.271.18.10697
10.1161/01.RES.0000119921.86460.37
10.1074/jbc.M206083200
10.1210/jc.86.5.1930
10.1074/jbc.270.45.26746
10.1006/bbrc.1999.0255
10.1074/jbc.C200312200
10.1074/jbc.M309469200
10.1074/jbc.M300365200
10.1074/jbc.M207198200
ContentType Journal Article
Copyright 2006 Elsevier B.V.
Copyright_xml – notice: 2006 Elsevier B.V.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.cca.2006.03.014
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
EISSN 1873-3492
EndPage 53
ExternalDocumentID 16697359
10_1016_j_cca_2006_03_014
S0009898106001963
Genre Validation Studies
Journal Article
GroupedDBID ---
--K
--M
.55
.GJ
.~1
0R~
1B1
1RT
1~.
1~5
29B
4.4
457
4G.
53G
5GY
5VS
6J9
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABBQC
ABFNM
ABFRF
ABGSF
ABJNI
ABLVK
ABMAC
ABMZM
ABUDA
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AHPSJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
G8K
GBLVA
HLW
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
LCYCR
LX3
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
RNS
ROL
RPZ
SBG
SDF
SDG
SDP
SES
SEW
SPCBC
SSH
SSU
SSZ
T5K
WH7
WUQ
X7M
XPP
ZA5
ZGI
~02
~G-
AATTM
AAXKI
AAYWO
AAYXX
ABDPE
ABWVN
ACIEU
ACLOT
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGQPQ
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
CITATION
EFKBS
~HD
CGR
CUY
CVF
ECM
EIF
NPM
PKN
7X8
AGCQF
ID FETCH-LOGICAL-c417t-3dd660151a3c6e85355625db930b1bc8393d54c524c9f4e978c18598cdfa3d9e3
IEDL.DBID .~1
ISSN 0009-8981
IngestDate Fri Sep 05 05:04:52 EDT 2025
Wed Feb 19 01:54:37 EST 2025
Wed Oct 01 01:59:17 EDT 2025
Thu Apr 24 23:01:09 EDT 2025
Fri Feb 23 02:29:12 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords PBS
HMW
SDS
Protease
MMW
LMW
Alb-LMW
Monoclonal antibody
Multimers
ELISA
MAb
Adiponectin
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c417t-3dd660151a3c6e85355625db930b1bc8393d54c524c9f4e978c18598cdfa3d9e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
PMID 16697359
PQID 68786833
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_68786833
pubmed_primary_16697359
crossref_primary_10_1016_j_cca_2006_03_014
crossref_citationtrail_10_1016_j_cca_2006_03_014
elsevier_sciencedirect_doi_10_1016_j_cca_2006_03_014
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2006-10-01
PublicationDateYYYYMMDD 2006-10-01
PublicationDate_xml – month: 10
  year: 2006
  text: 2006-10-01
  day: 01
PublicationDecade 2000
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Clinica chimica acta
PublicationTitleAlternate Clin Chim Acta
PublicationYear 2006
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Tsao, Murrey, Hug, Lee, Lodish (bib12) 2002; 277
Tsao, Tomas, Murrey (bib13) 2003; 278
Scherer, Williams, Fogliano, Baldini, Lodish (bib1) 1995; 270
Nakano, Tobe, Choi-Miura, Mazda, Tomita (bib4) 1996; 120
Davis (bib18) 1964; 121
Hu, Liang, Spiegelman (bib2) 1996; 271
Arita, Kihara, Ouchi (bib8) 1999; 257
Maeda, Okubo, Shimomura, Funahashi, Matsuzawa, Matsubara (bib3) 1996; 221
Waki, Yamauchi, Kamon (bib14) 2003; 278
Spranger, Kroke, Möhlig (bib6) 2002; 361
Tonelli, Li, Kishore (bib17) 2004; 53
Ouchi, Kihara, Arita (bib9) 2001; 103
Weyer, Funahashi, Tanaka (bib5) 2001; 86
Daimon, Yamaguchi, Oizumi (bib7) 2003; 26
Pajvani, Du, Combs (bib11) 2003; 278
Matsuda, Shimomura, Sata (bib10) 2002; 277
Pajvani, Hawkins, Combs (bib16) 2004; 279
Kobayashi, Ouchi, Kihara (bib15) 2004; 94
Waki (10.1016/j.cca.2006.03.014_bib14) 2003; 278
Maeda (10.1016/j.cca.2006.03.014_bib3) 1996; 221
Daimon (10.1016/j.cca.2006.03.014_bib7) 2003; 26
Pajvani (10.1016/j.cca.2006.03.014_bib11) 2003; 278
Arita (10.1016/j.cca.2006.03.014_bib8) 1999; 257
Tsao (10.1016/j.cca.2006.03.014_bib13) 2003; 278
Tonelli (10.1016/j.cca.2006.03.014_bib17) 2004; 53
Davis (10.1016/j.cca.2006.03.014_bib18) 1964; 121
Pajvani (10.1016/j.cca.2006.03.014_bib16) 2004; 279
Hu (10.1016/j.cca.2006.03.014_bib2) 1996; 271
Tsao (10.1016/j.cca.2006.03.014_bib12) 2002; 277
Nakano (10.1016/j.cca.2006.03.014_bib4) 1996; 120
Spranger (10.1016/j.cca.2006.03.014_bib6) 2002; 361
Matsuda (10.1016/j.cca.2006.03.014_bib10) 2002; 277
Scherer (10.1016/j.cca.2006.03.014_bib1) 1995; 270
Kobayashi (10.1016/j.cca.2006.03.014_bib15) 2004; 94
Ouchi (10.1016/j.cca.2006.03.014_bib9) 2001; 103
Weyer (10.1016/j.cca.2006.03.014_bib5) 2001; 86
References_xml – volume: 361
  start-page: 226
  year: 2002
  end-page: 228
  ident: bib6
  article-title: Adiponectin and protection against type 2 diabetes mellitus
  publication-title: Lancet
– volume: 103
  start-page: 1057
  year: 2001
  end-page: 1063
  ident: bib9
  article-title: Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages
  publication-title: Circulation
– volume: 278
  start-page: 50810
  year: 2003
  end-page: 50817
  ident: bib13
  article-title: Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways
  publication-title: J Biol Chem
– volume: 271
  start-page: 10697
  year: 1996
  end-page: 10703
  ident: bib2
  article-title: AdipoQ is a novel adipose-specific gene dysregulated in obesity
  publication-title: J Biol Chem
– volume: 277
  start-page: 29359
  year: 2002
  end-page: 29362
  ident: bib12
  article-title: Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30)
  publication-title: J Biol Chem
– volume: 53
  start-page: 1621
  year: 2004
  end-page: 1629
  ident: bib17
  article-title: Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes
  publication-title: Diabetes
– volume: 86
  start-page: 1930
  year: 2001
  end-page: 1935
  ident: bib5
  article-title: Hyperadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia
  publication-title: J Clin Endocrinol Metab
– volume: 279
  start-page: 12152
  year: 2004
  end-page: 12162
  ident: bib16
  article-title: Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity
  publication-title: J Biol Chem
– volume: 257
  start-page: 79
  year: 1999
  end-page: 83
  ident: bib8
  article-title: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
  publication-title: Biochem Biophys Res Commun
– volume: 121
  start-page: 404
  year: 1964
  end-page: 427
  ident: bib18
  article-title: Disc electrophoresis. II. Method and application to human serum proteins
  publication-title: Ann NY Acad Sci
– volume: 270
  start-page: 26746
  year: 1995
  end-page: 26749
  ident: bib1
  article-title: A novel serum protein similar to C1q, produced exclusively in adipocytes
  publication-title: J Biol Chem
– volume: 221
  start-page: 286
  year: 1996
  end-page: 296
  ident: bib3
  article-title: cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1)
  publication-title: Biochem Biophys Res Commun
– volume: 278
  start-page: 40352
  year: 2003
  end-page: 40363
  ident: bib14
  article-title: Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin
  publication-title: J Biol Chem
– volume: 94
  start-page: e27
  year: 2004
  end-page: e31
  ident: bib15
  article-title: Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin
  publication-title: Circ Res
– volume: 26
  start-page: 2015
  year: 2003
  end-page: 2020
  ident: bib7
  article-title: Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study
  publication-title: Diabetes Care
– volume: 277
  start-page: 37487
  year: 2002
  end-page: 37491
  ident: bib10
  article-title: Role of adiponectin in preventing vascular stenosis—the missing link of adipo-vascular axis
  publication-title: J Biol Chem
– volume: 278
  start-page: 9073
  year: 2003
  end-page: 9085
  ident: bib11
  article-title: Structure–function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity
  publication-title: J Biol Chem
– volume: 120
  start-page: 803
  year: 1996
  end-page: 812
  ident: bib4
  article-title: Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma
  publication-title: J Biochem (Tokyo)
– volume: 103
  start-page: 1057
  year: 2001
  ident: 10.1016/j.cca.2006.03.014_bib9
  article-title: Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages
  publication-title: Circulation
  doi: 10.1161/01.CIR.103.8.1057
– volume: 120
  start-page: 803
  year: 1996
  ident: 10.1016/j.cca.2006.03.014_bib4
  article-title: Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma
  publication-title: J Biochem (Tokyo)
  doi: 10.1093/oxfordjournals.jbchem.a021483
– volume: 53
  start-page: 1621
  year: 2004
  ident: 10.1016/j.cca.2006.03.014_bib17
  article-title: Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes
  publication-title: Diabetes
  doi: 10.2337/diabetes.53.6.1621
– volume: 361
  start-page: 226
  year: 2002
  ident: 10.1016/j.cca.2006.03.014_bib6
  article-title: Adiponectin and protection against type 2 diabetes mellitus
  publication-title: Lancet
  doi: 10.1016/S0140-6736(03)12255-6
– volume: 221
  start-page: 286
  year: 1996
  ident: 10.1016/j.cca.2006.03.014_bib3
  article-title: cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1)
  publication-title: Biochem Biophys Res Commun
  doi: 10.1006/bbrc.1996.0587
– volume: 279
  start-page: 12152
  year: 2004
  ident: 10.1016/j.cca.2006.03.014_bib16
  article-title: Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M311113200
– volume: 121
  start-page: 404
  year: 1964
  ident: 10.1016/j.cca.2006.03.014_bib18
  article-title: Disc electrophoresis. II. Method and application to human serum proteins
  publication-title: Ann NY Acad Sci
  doi: 10.1111/j.1749-6632.1964.tb14213.x
– volume: 26
  start-page: 2015
  year: 2003
  ident: 10.1016/j.cca.2006.03.014_bib7
  article-title: Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study
  publication-title: Diabetes Care
  doi: 10.2337/diacare.26.7.2015
– volume: 271
  start-page: 10697
  year: 1996
  ident: 10.1016/j.cca.2006.03.014_bib2
  article-title: AdipoQ is a novel adipose-specific gene dysregulated in obesity
  publication-title: J Biol Chem
  doi: 10.1074/jbc.271.18.10697
– volume: 94
  start-page: e27
  year: 2004
  ident: 10.1016/j.cca.2006.03.014_bib15
  article-title: Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000119921.86460.37
– volume: 277
  start-page: 37487
  year: 2002
  ident: 10.1016/j.cca.2006.03.014_bib10
  article-title: Role of adiponectin in preventing vascular stenosis—the missing link of adipo-vascular axis
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M206083200
– volume: 86
  start-page: 1930
  year: 2001
  ident: 10.1016/j.cca.2006.03.014_bib5
  article-title: Hyperadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.86.5.1930
– volume: 270
  start-page: 26746
  year: 1995
  ident: 10.1016/j.cca.2006.03.014_bib1
  article-title: A novel serum protein similar to C1q, produced exclusively in adipocytes
  publication-title: J Biol Chem
  doi: 10.1074/jbc.270.45.26746
– volume: 257
  start-page: 79
  year: 1999
  ident: 10.1016/j.cca.2006.03.014_bib8
  article-title: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
  publication-title: Biochem Biophys Res Commun
  doi: 10.1006/bbrc.1999.0255
– volume: 277
  start-page: 29359
  year: 2002
  ident: 10.1016/j.cca.2006.03.014_bib12
  article-title: Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30)
  publication-title: J Biol Chem
  doi: 10.1074/jbc.C200312200
– volume: 278
  start-page: 50810
  year: 2003
  ident: 10.1016/j.cca.2006.03.014_bib13
  article-title: Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M309469200
– volume: 278
  start-page: 40352
  year: 2003
  ident: 10.1016/j.cca.2006.03.014_bib14
  article-title: Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M300365200
– volume: 278
  start-page: 9073
  year: 2003
  ident: 10.1016/j.cca.2006.03.014_bib11
  article-title: Structure–function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M207198200
SSID ssj0004061
Score 2.2368271
Snippet Adiponectin, an antiatherogenic adipocyte-derived protein exists in human blood as multiple isoforms—trimeric low molecular weight (LMW), albumin-binding LMW...
Adiponectin, an antiatherogenic adipocyte-derived protein exists in human blood as multiple isoforms--trimeric low molecular weight (LMW), albumin-binding LMW...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 47
SubjectTerms Adiponectin
Adiponectin - analysis
Adiponectin - chemistry
Adiponectin - immunology
Antibodies, Monoclonal - immunology
Biopolymers - analysis
Blotting, Western
ELISA
Enzyme-Linked Immunosorbent Assay - methods
Humans
Monoclonal antibody
Multimers
Protease
Title A novel ELISA system for selective measurement of human adiponectin multimers by using proteases
URI https://dx.doi.org/10.1016/j.cca.2006.03.014
https://www.ncbi.nlm.nih.gov/pubmed/16697359
https://www.proquest.com/docview/68786833
Volume 372
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Complete Freedom Collection [SCCMFC]
  customDbUrl:
  eissn: 1873-3492
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004061
  issn: 0009-8981
  databaseCode: ACRLP
  dateStart: 19950116
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection
  customDbUrl:
  eissn: 1873-3492
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004061
  issn: 0009-8981
  databaseCode: .~1
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals [SCFCJ]
  customDbUrl:
  eissn: 1873-3492
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004061
  issn: 0009-8981
  databaseCode: AIKHN
  dateStart: 19950116
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1873-3492
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004061
  issn: 0009-8981
  databaseCode: AKRWK
  dateStart: 19560101
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NT8IwFG8IJurFKH7hB_bgyWQwaNdtR0IgoMJFSbjVrmsNBjciYOLFv93XbpN4gIPXpV1f3nt5H32v74fQLXhUDQSaCqPHHBor3xGaMUcJqoJAUqotnM9wxPpjej_xJiXUKd7CmLbK3PZnNt1a6_xLI-dmYz6dmje-rgE_hJzGDnkxEz_N9C_Q6fr3us3DOKwCTc2sLiqbtscLyM_rEaTuNukm37Qp9rQ-qHeIDvLgEbcz-o5QSSUVtNcpMNsqaHeYl8qP0UsbJ-mnmuHu4-CpjbOJzRhCVLyw0Ddg5fD7-oIQpxpbvD4s4uk8TcyKBNt2Q3OzjaMvbFrkX7Ed7ACub3GCxr3uc6fv5HAKjqRNf-mQOGaQfnlNQSRT4KY9k_zEUUjcqBlJiJRI7FHptagMNVWQXkpw5mEgYy1IHCpyisoJnH-OsNQsgn-JUAmQqQ9BJmgCA3MhWlpqSarILRjJZT5r3EBezHjRVPbGgfcGA5Nxl3DgfRXd_W6ZZ4M2ti2mhXT4H23h4Ai2bbspJMlBMKY0IhKVrhacBX7AAgKEn2UCXtPAWOgTL7z435GXaN9e2tj2vytUXn6s1DWEMcuoZvW0hnbag4f-6AdF3_DK
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwED5BkYAF8aY8PTAhBRLsOMlYVaAW2i6AxGYcx0ZFkFa0ReLfc3YcKgYYWCM_LnfWPXzn-wBO0aIaJNBmGGMesEIngTScB1oynaaKMePgfPoD3nlgN4_x4wK067cwtqzS6_5Kpztt7b9ceG5ejIdD-8Y3tOCHGNO4Ji90EZZYjDq5AUut7m1nMH8eGfKoBlSzE-rkpivzwj_wKQl6HkbsN_P0m_vpzND1Oqx5_5G0KhI3YEGXm7DSrmHbNmG577PlW_DUIuXoQ7-Sq173rkWqps0EvVQyceg3qOjI2_yOkIwMcZB9RBbD8ai0I0riKg7t5TbJP4mtkn8mrrcDWr_JNjxcX923O4FHVAgUi5JpQIuCYwQWR5IqrtFSxzb-KfKMhnmUK3SWaBEzFV8ylRmmMcJUaM-zVBVG0iLTdAcaJe6_B0QZnuNaMtMSxZqgn4mHgaPGkJdGGUWbENaMFMq3G7eoF6-irit7Ech7C4PJRUgF8r4JZ99TxlWvjb8Gs1o64seBEWgL_pp2UktSoGBsdkSWejSbCJ4mKU8pEr5bCXhOA-dZQuNs_39bnsBK577fE73u4PYAVt0djqsGPITG9H2mj9CrmebH_tR-AXrn83U
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+novel+ELISA+system+for+selective+measurement+of+human+adiponectin+multimers+by+using+proteases&rft.jtitle=Clinica+chimica+acta&rft.au=Ebinuma%2C+Hiroyuki&rft.au=Miyazaki%2C+Osamu&rft.au=Yago%2C+Hirokazu&rft.au=Hara%2C+Kazuo&rft.date=2006-10-01&rft.issn=0009-8981&rft.volume=372&rft.issue=1-2&rft.spage=47&rft.epage=53&rft_id=info:doi/10.1016%2Fj.cca.2006.03.014&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_cca_2006_03_014
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-8981&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-8981&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-8981&client=summon